| Literature DB >> 29197340 |
Hristo Todorov1,2, Inka Janssen3, Stefanie Honndorf4, Daniela Bause3, Antje Gottschalk3, Silke Baasner4, Thomas Volkert3, Valentin Faerber4, John F Stover4, Martin Westphal4,3, Björn Ellger3,5.
Abstract
BACKGROUND: Although mortality after cardiac surgery has significantly decreased in the last decade, patients still experience clinically relevant postoperative complications. Among others, atrial fibrillation (AF) is a common consequence of cardiac surgery, which is associated with prolonged hospitalization and increased mortality.Entities:
Keywords: C-reactive protein; CABG; Inflammation; Phosphate; Positive fluid balance; Postoperative atrial fibrillation; Valve surgery
Mesh:
Year: 2017 PMID: 29197340 PMCID: PMC5712135 DOI: 10.1186/s12871-017-0455-7
Source DB: PubMed Journal: BMC Anesthesiol ISSN: 1471-2253 Impact factor: 2.217
Fig. 1Overview of study population and subgroups for analysis. After excluding one patient who was a minor at the time of surgery, 999 patients were analysed in total. Subjects were allocated to 4 groups based on the pre- and postoperative occurrence of atrial fibrillation (AF)
Patient characteristics and clinical outcome of no AF vs new onset AF patients
| Variable | No AF | New onset AF |
|
|---|---|---|---|
| Age+ | 67 (58–75) | 74 (66–78) | <0.001# |
| Gender [number (%)] | ns§ | ||
| male | 430 (73.5) | 139 (71.6) | |
| female | 155 (26.5) | 55 (28.4) | |
| Weight at admission [kg]+ | 82 (72–94) | 82 (73.2–91) | ns# |
| ICU length of stay [d]+ | 1.8 (1.0–2.9) | 3.9 (2.1–5.9) | <0.001# |
| Duration of mechanical ventilation [h]+ | 6 (4–8) | 7 (5–10) | <0.001# |
| Dialysis [number (%)] | 11 (1.9) | 16 (8.2) | <0.001§ |
| Type of surgery [number (%)] | <0.001§ | ||
| CABG | 370 (63.2) | 108 (55.7) | |
| Valve | 169 (28.9) | 51 (26.3) | |
| CABG + valve | 46 (7.9) | 35 (18.0) | |
| Ventricular arrhythmias [number (%)] | 4 (0.7) | 6 (3.1) | <0.001$ |
| AV block III [number (%)] | 30 (5.1) | 12 (6.2) | ns§ |
| Epinephrine administration [number (%)] | 65 (11.1) | 35 (18.0) | <0.05§ |
| Dobutamine administration [number (%)] | 66 (11.3) | 29 (14.9) | ns§ |
| Mortality [number (%)] | 8 (1.4) | 8 (4.1) | <0.05$ |
Data are presented as absolute number and % (in brackets) or median together with the 1st and 3rd quartile (in brackets). P-values over the significance threshold of 0.05 are reported as not significant (ns)
+ Median (1st quartile - 3rd quartile), # Wilcoxon-Mann-Whitney test, § Chi-square test for independence, $ Fisher’s exact test
AV Atrio-ventricular, CABG Coronary artery bypass grafting, ICU Intensive care unit
Patient characteristics and clinical outcome of disappeared AF vs intermittent/permanent AF patients
| Variable | Disappeared AF | Intermittent/permanent AF |
|
|---|---|---|---|
| Age [years]+ | 75 (68–79) | 75 (70–78) | ns# |
| Gender [number (%)] | ns§ | ||
| male | 61 (68.5) | 90 (68.7) | |
| female | 28 (31.5) | 41 (31.3) | |
| Weight at admission [kg]+ | 80 (70–93) | 82 (72–97) | ns# |
| ICU length of stay [d]+ | 2.0 (1.0–3.9) | 3.9 (2.7–6.9) | <0.001# |
| Duration of mechanical ventilation [h]+ | 6 (4–9) | 7 (5–11) | <0.05# |
| Dialysis [number (%)] | 4 (4.5) | 8 (6.1) | ns$ |
| Type of surgery [number (%)] | ns$ | ||
| CABG | 35 (39.3) | 54 (41.2) | |
| Valve | 42 (47.2) | 54 (41.2) | |
| CABG + valve | 12 (13.5) | 23 (17.6) | |
| Ventricular arrhythmias [number (%)] | 0 (0) | 6 (4.6) | ns$ |
| AV block III [number (%)] | 17 (19.1) | 14 (10.7) | ns§ |
| Epinephrine administration [number (%)] | 19 (21.3) | 43 (32.8) | ns§ |
| Dobutamine administration [number (%)] | 17 (19.1) | 22 (16.8) | ns§ |
| Mortality [number (%)] | 2 (2.2) | 6 (4.6) | ns$ |
Data are presented as absolute numbers and % (in brackets) or median together with the 1st and 3rd quartile (in brackets). P-values over the significance threshold of 0.05 are reported as not significant (ns)
+ Median (1st quartile - 3rd quartile); # Wilcoxon-Mann-Whitney test; § Chi-square test for independence $ Fisher’s exact test
AV Atrio-ventricular; CABG Coronary artery bypass grafting; ICU Intensive care unit
Fig. 2Fluid balance changes over the time course of ICU stay. a Patients without atrial fibrillation (AF) versus patients with new onset AF. b Patients with disappeared AF versus patients with intermittent/permanent AF. Data are shown as median with 1st and 3rd quartile and minimum and maximum without outliers. Number of patients on each day is displayed under the graphs. *** p < 0.001, ** p < 0.01, * p < 0.05 (Wilcoxon-Mann-Whitney test)
Fig. 3Leukocyte concentration changes over the time course of ICU stay. a Patients without atrial fibrillation (AF) versus patients with new onset AF. b Patients with disappeared AF versus patients with intermittent/permanent AF. Data are shown as median with 1st and 3rd quartile and minimum and maximum without outliers. Number of patients on each day is displayed under the graphs. * p < 0.05 (Wilcoxon-Mann-Whitney test)
Fig. 4C-reactive protein concentration changes over the course of ICU stay. a Patients without atrial fibrillation (AF) versus patients with new onset AF. b Patients with disappeared AF versus patients with intermittent/permanent AF. Data are shown as median with 1st and 3rd quartile and minimum and maximum without outliers. Number of patients per day is displayed under the graphs. ** p < 0.01, * p < 0.05 (Wilcoxon-Mann-Whitney test)
Multiple logistic regression analysis for postoperative new onset AF as outcome variable
| Variable | OR (95% CI) |
|
|---|---|---|
| Age (per decade) | 1.448 (1.241–1.76) | <0.0001 |
| Type surgery (relative to CABG) | ||
| Valve | 1.396 (0.924–2.107) | 0.113 |
| CABG + valve | 1.711 (1.008–2.903) | 0.047 |
| Ventricular arrhythmias | 3.55 (0.859–14.66) | 0.08 |
| Epinephrine administration | 1.121 (0.662–1.9) | 0.67 |
| ALT concentration | 1.0 (0.999–1.0004) | 0.856 |
| C-reactive protein concentration | 1.06 (1.033–1.088) | <0.0001 |
| Creatinine concentration | 1.287 (1.022–1.621) | 0.032 |
| Calcium concentration | 1.01 (0.977–1.045) | 0.547 |
| Fluid balance (per litre) | 1.078 (0.962–1.207) | 0.195 |
| Horowitz index | 0.996 (0.993–0.999) | 0.012 |
Data are shown as odds ratios (OR) together with the 95% confidence interval (CI) and the corresponding p-value. For ALT, C-reactive protein, creatinine, calcium concentrations and fluid balance, the maximal recorded value per patient was used for model fitting. For the Horowitz index, the minimal recorded value was used for model estimation. Results from the univariate analyses are shown in Additional file 1: Table S1
AF Atrial fibrillation; ALT Alanine transaminase, CABG Coronary artery bypass grafting
Multiple logistic regression analysis for intermittent/permanent AF as outcome variable
| Variable | OR (95% CI) |
|
|---|---|---|
| AV block III | 0.511 (0.211–1.235) | 0.135 |
| Epinephrine administration | 1.03 (0.456–2.33) | 0.942 |
| C-reactive protein concentration | 1.032 (0.984–1.084) | 0.192 |
| Leukocytes concentration | 0.999 (0.94–1.061) | 0.976 |
| Creatinine concentration | 2.125 (1.114–4.052) | 0.022 |
| Fluid balance | 1.2 (0.942–1.527) | 0.139 |
| Phosphate concentration | 0.522 (0.342–0.795) | 0.003 |
| Sodium concentration | 1.035 (0.92–1.163) | 0.565 |
| Chloride concentration | 1.049 (0.939–1.17) | 0.396 |
| Horowitz index | 0.996 (0.99–1.001) | 0.12 |
Data are shown as odds ratios (OR) together with the 95% confidence interval (CI) and the corresponding p-value. For C-reactive protein, leukocytes, creatinine, fluid balance, phosphate, sodium and chloride the maximal recorded value was used for model fitting. For the Horowitz index, the minimal recorded value per patient was used for model estimation. Results from the univariate analyses are shown in Additional file 1: Table S2
AF Atrial fibrillation, AV Atrio-ventricular, CABG Coronary artery bypass grafting